New European approval: Fixed dose association of niraparib and abiraterone acetate in metastatic castration resistant prostate cancer with BRCA1/2  mutation

Bull Cancer. 2023 May 12:S0007-4551(23)00213-8. doi: 10.1016/j.bulcan.2023.04.018. Online ahead of print.NO ABSTRACTPMID:37183059 | DOI:10.1016/j.bulcan.2023.04.018

Source: Bulletin du Cancer - May 14, 2023 Category: Cancer & Oncology Authors: Herv é Bischoff Philippe Barth élémy Source Type: research